We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.31B
AUM Growth
+$72.1M
Cap. Flow
-$212M
Cap. Flow %
-6.41%
Top 10 Hldgs %
31.06%
Holding
111
New
31
Increased
21
Reduced
21
Closed
33

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$110M
2
AAPL icon
Apple
AAPL
+$94.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$94M
4
LRCX icon
Lam Research
LRCX
+$90.7M
5
AGN
Allergan plc
AGN
+$84.2M

Sector Composition

Rank Sector Weight
1 Healthcare 38.8%
2 Technology 9.31%
3 Communication Services 4.67%
4 Energy 3.99%
5 Financials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
101
DELISTED
Acorda Therapeutics
ACOR
-3,986
Closed -$12.7M
CLVS
102
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
-804,100
Closed -$15.4M
XENT
103
DELISTED
Intersect ENT, Inc
XENT
-57,089
Closed -$1.08M
AGN
104
DELISTED
Allergan plc
AGN
-314,106
Closed -$84.2M
TFCFA
105
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-1,132,946
Closed -$31.6M
AMSG
106
DELISTED
Amsurg Corp
AMSG
-152,424
Closed -$11.4M

Similar funds

PFM Health Sciences's Q2 2016 Portfolio in Review

As of Q2 2016, PFM Health Sciences held 111 positions worth $3.31B, up 2.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $212M in Q2 2016, closing 33 positions and reducing 21 holdings. Its most notable exit was Lam Research, an estimated $90.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $81.1M.

  • PFM Health Sciences's largest Q2 2016 buy was Biogen: 335,290 shares worth $81.1M.
  • PFM Health Sciences added most to Aetna Inc in Q2 2016, an estimated $92.4M increase.
  • PFM Health Sciences's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $110M.
  • PFM Health Sciences fully exited Lam Research in Q2 2016, selling an estimated $90.7M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $3.31B portfolio in Q2 2016.
  • PFM Health Sciences opened 31 new positions and closed 33 in Q2 2016.
  • PFM Health Sciences's portfolio value rose 2.2% quarter-over-quarter to $3.31B.

Based on PFM Health Sciences's 13F filing for Q2 2016, filed 15 Aug 2016.